SXC Health solutions announces second quarter financial results
finance.yahoo.com
Q2 2010 Highlights
------------------
- Revenue grew 49% on a year over year basis to $479.4 million,
compared to $320.8 million in Q2 2009
- Gross profit was $53.7 million, compared to $47.2 million in Q2 2009
- Adjusted EBITDA(1) was $31.5 million, compared to $23.7 million in Q2
2009
- GAAP net income increased to $17.1 million, or $0.55 per share
(fully-diluted), compared to $12.0 million, or $0.47 per share
(fully-diluted), in Q2 2009
- Non-GAAP adjusted earnings per share(1) (diluted) was $0.58, which
excludes the NMHC transaction-related amortization, compared to $0.53
in Q2 2009
- Cash from operations was $39.5 million, compared to $19.8 million in
Q2 2009
- Adjusted prescription claim volume(1) for the PBM segment was 11.8
million, compared to 8.9 million in Q2 2009
- Transaction processing volume for the HCIT segment was 99.6 million,
compared to 98.8 million in Q2 2009
- Mail order penetration was 11.5%, compared to 8% in Q2 2009
- Successfully converted another HCIT client to PBM services in the
quarter
- Completed development and testing of software to support the National
Council for Prescription Drug Programs (NCPDP) version D.0 of the
NCPDP Telecommunication Standard, well ahead of the January 1, 2011
compliance date |
